II
WST icon

IFM Investors’s West Pharmaceutical WST Stock Holding History

IFM Investors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.88M Buy
16,381
+2,608
+19% +$797K 0.04% 375
2026
Q1 		$3.45M Buy
13,773
+43
+0.3% +$10.7K 0.03% 454
2025
Q4 		$3.78M Buy
13,730
+49
+0.4% +$13.4K 0.03% 442
2025
Q3 		$3.58M Hold
13,681
– – 0.03% 435
2025
Q2 		$2.99M Buy
13,681
+828
+6% +$177K 0.03% 453
2025
Q1 		$2.88M Sell
12,853
-256
-2% -$70.6K 0.03% 447
2024
Q4 		$4.29M Sell
13,109
-1,414
-10% -$445K 0.04% 366
2024
Q3 		$4.36M Sell
14,523
-87
-0.6% -$26.6K 0.04% 380
2024
Q2 		$4.81M Buy
14,610
+47
+0.3% +$16.6K 0.05% 348
2024
Q1 		$5.76M Buy
14,563
+112
+0.8% +$41.4K 0.06% 304
2023
Q4 		$5.09M Buy
14,451
+178
+1% +$63K 0.06% 300
2023
Q3 		$5.36M Buy
14,273
+548
+4% +$212K 0.07% 279
2023
Q2 		$5.25M Buy
13,725
+196
+1% +$70K 0.07% 291
2023
Q1 		$4.69M Buy
13,529
+215
+2% +$62.8K 0.07% 298
2022
Q4 		$3.13M Hold
13,314
– – 0.05% 364
2022
Q3 		$3.28M Buy
13,314
+526
+4% +$160K 0.06% 329
2022
Q2 		$3.87M Buy
12,788
+1,654
+15% +$538K 0.07% 302
2022
Q1 		$4.57M Buy
11,134
+1,682
+18% +$658K 0.07% 281
2021
Q4 		$4.43M Sell
9,452
-128
-1% -$55.1K 0.08% 249
2021
Q3 		$4.07M Buy
9,580
+34
+0.4% +$14.3K 0.08% 233
2021
Q2 		$3.43M Buy
9,546
+1,251
+15% +$413K 0.07% 284
2021
Q1 		$2.34M Buy
8,295
+1,120
+16% +$321K 0.06% 314
2020
Q4 		$2.03M Buy
7,175
+1,148
+19% +$322K 0.06% 295
2020
Q3 		$1.66M Buy
6,027
+634
+12% +$168K 0.07% 276
2020
Q2 		$1.23M Sell
5,393
-2,425
-31% -$476K 0.06% 305
2020
Q1 		$1.19M Buy
7,818
+2,710
+53% +$417K 0.05% 338
2019
Q4 		$768K Buy
+5,108
New +$744K 0.03% 533

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return

IFM Investors's WST Position: Q2 2026 in Review

IFM Investors increased its West Pharmaceutical (WST) stake by 19% in Q2 2026, buying an estimated $797K and bringing the position to 16,381 shares worth $5.88M. The position accounts for 0.04% of the portfolio, ranked #375.

IFM Investors first reported a position in WST in Q4 2019 and has held it in 27 quarters since. 189 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • IFM Investors held 16,381 shares of West Pharmaceutical worth $5.88M as of Q2 2026.
  • IFM Investors bought 2,608 West Pharmaceutical shares in Q2 2026, an estimated $797K.
  • West Pharmaceutical made up 0.04% of IFM Investors's portfolio in Q2 2026, its #375 holding.
  • IFM Investors first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • 189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.